Heres a bit more about why we prefer Limitless Life : Commitment to Quality Control: Limitless Life works with three independent laboratories that conduct testing on each batch to ensure product quality, purity, and potency
[3] [7] As of 2024, retatrutide has no UK marketing authorisation granted by the Medicines and Healthcare products Regulatory Agency (MHRA), and it has not received a marketing authorisation from the European Medicines Agency (EMA)
A monthly peptide therapy supply (various doses or injections) may be in the $500-$1,500 range
Claims surrounding BPC-157 benefits derive exclusively from preclinical animal studies, which regulatory bodies do not accept as sufficient evidence for human therapeutic approval
BPC-157 is a research peptide that has not been approved by Health Canada or the FDA for human therapeutic use
Ongoing courses help maintain optimal levels, especially during periods of stress, intense work, or low sun exposure